NDC 63402-513

NDC 63402-513

NDC 63402-513 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 63402-513
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 63402-513-05 [63402051305]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-21
Marketing End Date2014-04-08

NDC 63402-513-36 [63402051336]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-21
Marketing End Date2014-04-08

NDC 63402-513-00 [63402051300]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1999-04-01
Marketing End Date2017-02-28

NDC 63402-513-03 [63402051303]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2011-12-21
Marketing End Date2014-04-08

NDC 63402-513-24 [63402051324]

Xopenex SOLUTION
Marketing CategoryNDA
Application NumberNDA020837
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1999-04-01
Marketing End Date2017-02-28

Drug Details

Medicade Reported Pricing

63402051324 XOPENEX 1.25 MG/3 ML SOLUTION

Pricing Unit: ML | Drug Type:

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.